Search

everythinglearnresearchcommunity

for

Search:↓

Krt15+ cells in mice can resist radiation, regenerate tissue, and start tumors, suggesting new cancer treatment targets.

5-Alpha reductase inhibitors may prevent prostate cancer but are not widely used due to concerns about trial relevance and potential risks, and more research is needed to confirm long-term benefits.

Vitamin E in the diet might help protect against hair loss caused by the chemotherapy drug doxorubicin in rabbits.

New cancer treatments show promise in reducing tumor growth and improving skin regeneration in mice.

Steroidogenesis inhibitors change but don't stop androgen production in prostate cancer.

Nanocarriers can improve skin treatments after cancer therapy by enhancing antioxidant delivery and effectiveness.

The model effectively mimics radiation-induced skin damage for future research.

Retinoic acid reduces cell damage from oxidative stress.

Using CDK inhibitors on rats showed a reduction in chemotherapy-caused hair loss, but later experiments could not repeat these results.

Standardized protocols are crucial for safe and infection-free platelet-rich plasma therapy.

Adipose-derived stem cells help heal radiation skin damage by reducing cell death and inflammation.

Targeted protein degraders show promise in treating cancer but need to target more diverse proteins.

PROTACs offer new ways to treat hard-to-target diseases, with promising drugs for cancer in advanced trials.

Radiation reduced zinc levels, growth, organ weights, and hair pigment in swine.

Tribulus terrestris may protect the liver from drug damage.

Radiotherapy is a good option when further surgery for skin cancer isn't preferred, but more research is needed to compare it with other methods.

5α-reduced progestogens may reduce mood issues and brain damage linked to HIV-1 Tat.

Two new compounds can block androgen receptor activity in different ways and may lead to new treatments for androgen-related diseases.

Chemotherapy and radiotherapy can cause skin side effects like rashes, hair loss, and nail changes, which are usually managed with conservative treatments.

Stereotactic body radiation therapy and radiosurgery are advanced, precise treatments that target tumors while protecting healthy tissue.

TS-13 effectively stops tumor growth and reduces chemotherapy side effects.

Persistent radiation-induced hair loss is dose-dependent, and treatments like topical minoxidil can be effective.

Microbeam Radiation Therapy is effective, but using a linear accelerator reduces its benefits.

EGFR cancer drugs often cause a rash, which can lead to distress and isolation, but may also improve outcomes for some cancer patients. Current treatments for the rash are limited, but a compound called menadione shows promise.

5α-reductase inhibitors lower overall prostate cancer risk but not high-grade cancer risk; longer-term screening and new treatments show promise.

Platelet-rich plasma doesn't prevent hair loss from chemotherapy, and mononuclear cells only help against hair loss from one specific chemotherapy drug.

Early diagnosis, decontamination, and supportive care are crucial for managing acute radiation syndrome.

5 alpha-reductase inhibitors like finasteride may lower prostate cancer risk and improve cancer screening.

New treatments may restore cancer-blocking proteins, slow prostate cancer, identify drug targets, and potentially regrow hair.